prednisolone and Pemphigoid, Bullous studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Pemphigoid, Bullous: A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.

Research Excerpts

Excerpt	Relevance	Reference
"Starting patients on doxycycline is non-inferior to standard treatment with oral prednisolone for short-term blister control in bullous pemphigoid and significantly safer in the long-term."	9.24	Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. ( Chalmers, JR; Chapman, A; Childs, M; Godec, TR; Harman, K; Kirtschig, G; Mason, J; Nunn, AJ; Schmidt, E; Walton, S; Whitham, D; Williams, HC; Wojnarowska, F, 2017)
"We conclude that neither azathioprine nor plasma exchange is effective enough to be used routinely as an adjuvant to corticosteroids in the management of bullous pemphigoid."	9.07	Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. ( Bernard, P; Foldès-Pauwels, C; Guillaume, JC; Guillot, B; Joly, P; Labeille, B; Picard, C; Prigent, F; Prost, C; Vaillant, L, 1993)
"Oral prednisolone is the mainstay treatment for bullous pemphigoid, an autoimmune blistering skin disorder affecting older people."	8.02	Long-term oral prednisolone exposure in primary care for bullous pemphigoid: population-based study. ( Chalmers, JR; Gran, S; Harman, KE; Hippisley-Cox, J; Langan, SM; Persson, MS; Thomas, KS; Vinogradova, Y, 2021)
"Corticosteroids, especially prednisolone or prednisone, are the most commonly used drugs for the treatment of bullous pemphigoid (BP)."	7.77	Association between effective dose of prednisolone, alone or in conjunction with other immunosuppressants, and titre of anti-bullous pemphigoid 180 antibody: a retrospective study of 42 cases. ( Fujiwara, H; Ito, M; Miida, H, 2011)
"Twenty-six patients with bullous pemphigoid were treated with a combination of chlorambucil and a systemic corticosteroid; 23 completed treatment."	7.68	The use of chlorambucil in the treatment of bullous pemphigoid. ( Hutchinson, PE; Milligan, A, 1990)
"Doxycycline and prednisolone to treat bullous pemphigoid were compared within a randomized controlled trial (RCT)."	6.87	Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial. ( Chalmers, JR; Chapman, A; Childs, M; Godec, T; Harman, K; Kirtschig, G; Mason, JM; Nunn, AJ; Schmidt, E; Walton, S; Whitham, D; Williams, HC; Wojnarowska, F, 2018)
" The limitations of the trial were the wide non-inferiority margin, the moderate dropout rate and that serious adverse event collection was unblinded."	6.84	A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracycl ( Chalmers, JR; Chapman, A; Childs, M; Godec, TR; Harman, K; Kirtschig, G; Mason, J; Nunn, AJ; Schmidt, E; Walton, S; Whitham, D; Williams, HC; Wojnarowska, F, 2017)
"The primary outcomes are: (i) effectiveness (assessor-blinded blister count at 6 weeks) and (ii) safety [proportion of patients experiencing ≥ grade 3 adverse events (i."	6.80	A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines ( Bratton, DJ; Chalmers, JR; Foster, KA; Kirtschig, G; Mason, J; Nunn, AJ; Whitham, D; Williams, HC; Wojnarowska, F, 2015)
"Prednisolone (PO) was assayed using high-performance liquid chromatography (HPLC)."	6.67	Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients. ( Chosidow, O; Diquet, B; Etienne, SD; Herson, S; Puech, AJ; Vandermeersch, V; Vu-Thi-My-Le, C, 1991)
"Bullous pemphigoid is a bullous skin disease associated with basal membrane antibodies."	6.67	[Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study]. ( Dreno, B; Giordano, F; Lacour, P; Lota, I; Montpoint, S; Royer, P; Sassolas, B, 1993)
"Systemic corticosteroids for the treatment of bullous pemphigoid are an accepted therapeutic measure among dermatologists."	6.65	[Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study]. ( Guillaume, JC; Morel, P, 1984)
"Pemphigus and pemphigoid are different types of autoimmune bullous disease and can occur in the same patient."	5.36	Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist. ( Hasegawa, J; Hashimoto, T; Ohyama, B; Oyama, B; Saida, T; Shiohara, J; Takata, M; Uhara, H; Yoshida, K, 2010)
" During progressive decrease of steroid dosage 5 of these 8 patients remained well (mean follow-up 7 months), 2 relapsed and one died of marasmus."	5.27	[Treatment of bullous pemphigoid by plasma exchange and prednisolone]. ( Guillaume, JC; Revuz, J; Roujeau, JC; Touraine, R; Touzet, C, 1985)
" Prednisolone therapy did not effect remission at the dosage of 4."	5.26	Bullous pemphigoid refractory to recommended dosage of prednisolone in a dog. ( Barta, O; Ochoa, R; Turnwald, GH, 1981)
"Starting patients on doxycycline is non-inferior to standard treatment with oral prednisolone for short-term blister control in bullous pemphigoid and significantly safer in the long-term."	5.24	Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. ( Chalmers, JR; Chapman, A; Childs, M; Godec, TR; Harman, K; Kirtschig, G; Mason, J; Nunn, AJ; Schmidt, E; Walton, S; Whitham, D; Williams, HC; Wojnarowska, F, 2017)
"We conclude that neither azathioprine nor plasma exchange is effective enough to be used routinely as an adjuvant to corticosteroids in the management of bullous pemphigoid."	5.07	Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. ( Bernard, P; Foldès-Pauwels, C; Guillaume, JC; Guillot, B; Joly, P; Labeille, B; Picard, C; Prigent, F; Prost, C; Vaillant, L, 1993)
"Oral prednisolone is the mainstay treatment for bullous pemphigoid, an autoimmune blistering skin disorder affecting older people."	4.02	Long-term oral prednisolone exposure in primary care for bullous pemphigoid: population-based study. ( Chalmers, JR; Gran, S; Harman, KE; Hippisley-Cox, J; Langan, SM; Persson, MS; Thomas, KS; Vinogradova, Y, 2021)
" The STOP GAP trial showed that prednisolone and ciclosporin are equally effective as first-line systemic treatment for pyoderma gangrenosum."	3.85	Generating new evidence, improving clinical practice and developing research capacity: the benefits of recruiting to the U.K. Dermatology Clinical Trials Network's STOP GAP and BLISTER trials. ( Batchelor, JM; Chapman, A; Craig, FE; Harman, KE; Kirtschig, G; Martin-Clavijo, A; Ormerod, AD; Walton, S; Williams, HC, 2017)
"Corticosteroids, especially prednisolone or prednisone, are the most commonly used drugs for the treatment of bullous pemphigoid (BP)."	3.77	Association between effective dose of prednisolone, alone or in conjunction with other immunosuppressants, and titre of anti-bullous pemphigoid 180 antibody: a retrospective study of 42 cases. ( Fujiwara, H; Ito, M; Miida, H, 2011)
"A 78-year-old man administered prednisolone and cyclosporin A for bullous pemphigoid and found in computed tomography (CT) to have a left-lung nodule was suspected of having a fungal infection due to elevated blood (1-->3)-beta-D-glucan."	3.75	[A case of disseminated nocardiosis followed by pneumocystis pneumonia in a patient prescribed corticosteroid and cyclosporin A and having elevated blood (1-->3)-beta-D-glucan]. ( Harada, S; Hatakeyama, S; Itoyama, S; Kitazawa, T; Koike, K; Ota, Y, 2009)
"We studied the precise correlation between ELISA values for BP180 NC16A and the alternations of disease activity in 5 patients with bullous pemphigoid (BP) during various treatments and tried to answer the question of how we can use ELISA to determine the timing of prednisolone (PSL) tapering."	3.72	Monitoring of ELISA for anti-BP180 antibodies: clinical and therapeutic analysis of steroid-treated patients with bullous pemphigoid. ( Esaki, C; Ichiki, Y; Izumi, T; Kitajima, Y, 2004)
"We report a 38-year-old woman with myoma uteri and bullous pemphigoid controlled by oral prednisolone (7."	3.71	[Recurrence of bullous pemphigoid after surgery: report of a case]. ( Higa, K; Matsunaga, M; Nishimura, E; Shirota, K; Yoshida, T, 2001)
" Histology and immunofluorescence confirmed a clinical diagnosis of bullous pemphigoid and her condition resolved rapidly after treatment with prednisolone."	3.71	Development of a bullous pemphigoid after split-skin grafting. ( Ghura, HS; Johnston, GA; Milligan, A, 2001)
" We report two cases where multifocal Kaposi's sarcoma developed following iatrogenic immunosuppression with prednisolone and azathioprine for bullous pemphigoid."	3.69	Kaposi's sarcoma associated with immunosuppression for bullous pemphigoid. ( Cerio, R; Halpern, SM; Kirby, JT; Parslew, R; Sharpe, GR, 1997)
"The goal of this study was to determine levels of serine proteinases and their inhibitors in serum and blister fluid of patients with pemphigus vulgaris (PV) and bullous pemphigoid (BP) in the course of treatment with prednisolone and proteinase inhibitors such as Contrycal and epsilon-aminocaproic acid."	3.68	Decompensation in proteinase-inhibitor system and application of proteinase inhibitors in pemphigus and pemphigoid. ( Grando, SA, 1992)
"Twenty-six patients with bullous pemphigoid were treated with a combination of chlorambucil and a systemic corticosteroid; 23 completed treatment."	3.68	The use of chlorambucil in the treatment of bullous pemphigoid. ( Hutchinson, PE; Milligan, A, 1990)
"Doxycycline and prednisolone to treat bullous pemphigoid were compared within a randomized controlled trial (RCT)."	2.87	Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial. ( Chalmers, JR; Chapman, A; Childs, M; Godec, T; Harman, K; Kirtschig, G; Mason, JM; Nunn, AJ; Schmidt, E; Walton, S; Whitham, D; Williams, HC; Wojnarowska, F, 2018)
" The limitations of the trial were the wide non-inferiority margin, the moderate dropout rate and that serious adverse event collection was unblinded."	2.84	A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracycl ( Chalmers, JR; Chapman, A; Childs, M; Godec, TR; Harman, K; Kirtschig, G; Mason, J; Nunn, AJ; Schmidt, E; Walton, S; Whitham, D; Williams, HC; Wojnarowska, F, 2017)
"The average age at blisters eruption was 62."	2.82	Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review. ( Li, SZ; Wang, SH; Xie, YH; Zuo, YG, 2022)
"The primary outcomes are: (i) effectiveness (assessor-blinded blister count at 6 weeks) and (ii) safety [proportion of patients experiencing ≥ grade 3 adverse events (i."	2.80	A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines ( Bratton, DJ; Chalmers, JR; Foster, KA; Kirtschig, G; Mason, J; Nunn, AJ; Whitham, D; Williams, HC; Wojnarowska, F, 2015)
"Prednisolone (PO) was assayed using high-performance liquid chromatography (HPLC)."	2.67	Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients. ( Chosidow, O; Diquet, B; Etienne, SD; Herson, S; Puech, AJ; Vandermeersch, V; Vu-Thi-My-Le, C, 1991)
"Bullous pemphigoid is a bullous skin disease associated with basal membrane antibodies."	2.67	[Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study]. ( Dreno, B; Giordano, F; Lacour, P; Lota, I; Montpoint, S; Royer, P; Sassolas, B, 1993)
"Systemic corticosteroids for the treatment of bullous pemphigoid are an accepted therapeutic measure among dermatologists."	2.65	[Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study]. ( Guillaume, JC; Morel, P, 1984)
"Bullous pemphigoid is the most common autoimmune bullous disease in the West."	2.43	Interventions for bullous pemphigoid. ( Hollis, S; Khumalo, N; Kirtschig, G; Middleton, P; Murrell, D; Wojnarowska, F, 2005)
"Bullous pemphigoid is the most common autoimmune bullous disease in the West."	2.42	Interventions for bullous pemphigoid. ( Hollis, S; Khumalo, N; Kirtschig, G; Middleton, P; Murrell, D; Wojnarowska, F, 2003)
"Bullous pemphigoid is thought to have many problems during perioperative period, such as hypoproteinemia and delayed wound healing due to administration of the steroid, therefore intensive care is necessary in the perioperative care."	2.39	[A case of resected lung cancer associated with bullous pemphigoid]. ( Endo, K; Ishikawa, S; Mitsui, K; Mitsui, T; Onizuka, M; Sato, Y, 1996)
"A review of canine pemphigus vulgaris, pemphigus vegetans, pemphigus foliaceus, pemphigus erythematosus, and bullous pemphigoid shows them to share many clinicopathologic similarities with their human counterparts."	2.36	Pemphigus and pemphigoid in dog and man: comparative aspects. ( Lewis, RM; Scott, DW, 1981)
"Histologically, subepidermal blisters without eosinophilic infiltration were observed."	1.91	A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma. ( Fujimura, Y; Fuke, S; Izumi, K; Tanaka, A; Ujiie, H, 2023)
" At the time points that prednisolone dosage was higher, higher levels of ALT, but no difference in AST levels was noted."	1.72	Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients: New evidence for the safety of rituximab. ( Aryanian, Z; Balighi, K; Daneshpazhooh, M; Hatami, P; Mahmoudi, H; Mohseniafshar, Z; Soori, T; Tahooneban, A; Tavakolpour, S, 2022)
"Two patients had recurrence of their factor VIII inhibitor during the tapering of their immunosuppression."	1.62	Bullous pemphigoid is a common associated disorder with acquired haemophilia A. ( Abdul-Halim, NA; Ng, HJ, 2021)
"A 56-year-old Japanese male with type 2 diabetes on hemodialysis was referred to our hospital due to worsened blisters."	1.56	Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid, likely triggered by scabies, in a hemodialysis patient with human leukocyte antigen-DQB1*03:01. ( Hata, K; Hibi, A; Hosokawa, N; Ishihara, Y; Kasahara, Y; Nakagawa, T, 2020)
"Bronchiolitis obliterans is a small-airway obstructive lung disease for which immunologically mediated pathogenesis is supposed."	1.46	Non-paraneoplastic autoimmune subepidermal bullous disease associated with fatal bronchiolitis obliterans. ( Abe, R; Hashidate, H; Hashimoto, T; Hokari, S; Ishii, N; Kanekura, T; Kawai, K; Narita, JI; Orime, M; Tomiyama, K; Tsuda, A; Uchida, Y; Yokoyama, H; Yoshida, S, 2017)
"She was diagnosed with herpes simplex encephalitis (HSE), and acyclovir was started on the first day of admission."	1.43	Herpes simplex encephalitis without cerebrospinal fluid pleocytosis in a patient with bullous pemphigoid: a case report. ( Hanafusa, T; Kakiuti, K; Kimura, F; Nakajima, H; Nakamura, Y; Tani, H, 2016)
"Bullous pemphigoid is a blistering disorder which can be idiopathic or arise secondary to drugs or trauma; however, blistering arising within surgical scars is rare."	1.43	Bullous Pemphigoid Arising in Lower Leg Vein Graft Incision Site. ( McKenna, K; Murphy, B; Walsh, M, 2016)
"First-line treatments of bullous pemphigoid (BP) are topical and systemic glucocorticoids (GC)."	1.43	Expression of Glucocorticoid Receptors GRα and GRβ in Bullous Pemphigoid. ( Glumoff, V; Haapasaari, KM; Hägg, PM; Hurskainen, T; Kokkonen, N; Kubin, ME; Kulmala, P; Tasanen, K; Uchida, T; Väyrynen, JP, 2016)
"Bullous pemphigoid is most commonly seen in elderly patients, however, an increasing number of cases in children have been reported."	1.42	[Bullous pemphigoid may also be seen in children]. ( Lauritzen, AF; Lei, U; Madsen, JO, 2015)
"Anti-p200 pemphigoid is a recently described autoimmune subepidermal bullous dermatosis characterized by its target antigen and the associated anatomoclinical picture."	1.39	[Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)]. ( Delaplace, M; Estève, E; Raffin, D; Roussel, A, 2013)
"There is much less experience in the treatment of bullous pemphigoid (BP)."	1.38	Adjuvant treatment of recalcitrant bullous pemphigoid with immunoadsorption. ( Benoit, S; Bröcker, EB; Klinker, E; Müller, PA; Stoevesandt, J, 2012)
"Dyshidrosiform Bullous pemphigoid is a well-known entity, but dyshidrosiform pemphigus vulgaris has rarely been described."	1.36	Dyshidrosiform Pemphigus vulgaris: Report of an unusual case. ( Gharami, RC; Ghosh, K; Kumar, P; Mondal, A, 2010)
"Bullous pemphigoid is an autoimmune subepidermal blistering disease associated with autoantibodies against BP180 and BP230."	1.36	Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid. ( Hashimoto, T; Ikeda, S; Mayuzumi, N; Yamaki, F, 2010)
"Pemphigus and pemphigoid are different types of autoimmune bullous disease and can occur in the same patient."	1.36	Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist. ( Hasegawa, J; Hashimoto, T; Ohyama, B; Oyama, B; Saida, T; Shiohara, J; Takata, M; Uhara, H; Yoshida, K, 2010)
"The occurrence of two autoimmune blistering conditions in the same patient is a rare event, and may suggest an intermolecular epitope-spreading phenomenon."	1.33	Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid. ( Aoki, V; Maeda, JY; Maruta, CW; Moura, AK; Prisayanh, PS; Santi, CG, 2006)
"4 years (median); a daily glucocorticosteroid dosage of more than 37 mg (75th quartile) at discharge, with a multivariate risk estimate of 2."	1.31	Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. ( Baima, B; Büchner, L; Büdinger, L; Hertl, M; Jung, M; Kaiser, HW; Kippes, W; Mecking, D; Messer, G; Messmer, EM; Meurer, M; Partscht, K; Pawelczyk, B; Pfeiffer, C; Prudlo, C; Rzany, B; Schuhmann, M; Sinkgraven, R; Sticherling, M; Zillikens, D, 2002)
"Bullous pemphigoid is an autoimmune bullous disease that is rare in children and infants."	1.30	Bullous pemphigoid in an infant: a case report and literature review. ( Kulthanan, K; Viravan, S; Wisuthsarewong, W, 1997)
"We describe the occurrence of autoimmune haemolytic anaemia (AIHA) in a patient who had had both idiopathic thrombocytopenic purpura (ITP) and bullous pemphigoid (BP) for about 10 years."	1.30	Combination chemotherapy in a patient with severe multiple systemic autoimmune disease. ( Akagi, T; Kawamura, S; Munakata, A; Takami, H; Tamai, Y, 1998)
"The bleeding was mitigated by transfusion of factor VIII concentrate combined with steroid pulse therapy."	1.30	[Recurrent bleeding tendency due to factor VIII inhibitor during therapy for bullous pemphigoid]. ( Iwata, N; Kuboki, T; Kudo, T; Morimoto, I, 1999)
"Bullous pemphigoid is rare in infancy and childhood with only 40 cases previously reported."	1.29	Bullous pemphigoid in infancy--a case report including new immunoblotting observations. ( Black, MM; Hashimoto, T; Nishikawa, T; Ostlere, LS; Rustin, MH; Stevens, H, 1993)
"Bullous pemphigoid is rare during the childhood."	1.29	[Pemphigoid in children]. ( Chouvet, B; Claudy, A; Cozzani, E; Faure, M; Jay, P; Kanitakis, J; Misery, L, 1994)
"Bullous pemphigoid is a clinically heterogeneous disease although little is known of the factors affecting its course and outcome."	1.28	Lack of predictive factors for the clinical course of bullous pemphigoid. ( Venning, VA; Wojnarowska, F, 1992)
"Pemphigus vulgaris was the commonest bullous disease."	1.28	Bullous diseases in Malaysia: epidemiology and natural history. ( Adam, BA, 1992)
" During progressive decrease of steroid dosage 5 of these 8 patients remained well (mean follow-up 7 months), 2 relapsed and one died of marasmus."	1.27	[Treatment of bullous pemphigoid by plasma exchange and prednisolone]. ( Guillaume, JC; Revuz, J; Roujeau, JC; Touraine, R; Touzet, C, 1985)
"Prednisolone was given orally when complete control--absence of any new lesion--was achieved."	1.27	[Immediate treatment of bullous pemphigus with a corticosteroid-cyclophosphamide combination]. ( Klene, C; Maleville, J; Taïeb, A, 1986)
" Prednisolone therapy did not effect remission at the dosage of 4."	1.26	Bullous pemphigoid refractory to recommended dosage of prednisolone in a dog. ( Barta, O; Ochoa, R; Turnwald, GH, 1981)

Research

Studies (175)

Authors

Clinical Trials (2)

Trial Overview

Trial Outcomes

B Cell Number at Week 24

Timeframe	Studies, this research(%)	All Research%
pre-1990	15 (8.57)	18.7374
1990's	31 (17.71)	18.2507
2000's	40 (22.86)	29.6817
2010's	74 (42.29)	24.3611
2020's	15 (8.57)	2.80

Authors	Studies
Kitao, R	1
Fukumoto, T	1
Hashimoto, T	22
Izumi, K	4
Jimbo, H	1
Takemori, C	1
Nishigori, C	1
Persson, MS	1
Harman, KE	3
Thomas, KS	2
Chalmers, JR	6
Vinogradova, Y	2
Langan, SM	2
Hippisley-Cox, J	2
Gran, S	2
Xie, YH	1
Wang, SH	1
Li, SZ	1
Zuo, YG	1
Aryanian, Z	1
Tahooneban, A	1
Balighi, K	2
Daneshpazhooh, M	1
Mahmoudi, H	1
Soori, T	1
Mohseniafshar, Z	1
Tavakolpour, S	1
Hatami, P	1
Tanaka, A	1
Fujimura, Y	1
Fuke, S	1
Ujiie, H	2
Fenne, IJ	1
Askildsen Oftebro, G	1
Vestergaard, C	1
Frølunde, AS	1
Bech, R	1
Hibi, A	1
Kasahara, Y	1
Ishihara, Y	1
Hata, K	1
Hosokawa, N	1
Nakagawa, T	1
Pankakoski, A	1
Panelius, J	1
Salava, A	1
Kluger, N	2
Yokoyama, R	1
Hayashi, R	1
Umemori, Y	1
Arimatsu, A	1
Yuki, A	1
Abe, R	2
Apalla, Z	1
Lallas, A	1
Delli, F	1
Lazaridou, E	1
Papalampou, S	1
Apostolidou, S	1
Gerochristou, M	1
Rigopoulos, D	1
Stratigos, A	2
Nikolaou, V	1
Mangin, MA	1
Kanitakis, J	2
Jullien, D	1
Lesort, C	1
Abdul-Halim, NA	1
Ng, HJ	1
Kim, YB	1
Choi, HS	1
Cho, HK	1
Seo, GW	1
Persson, MSM	1
Ujiie, I	1
Iwata, H	1
Yoshimoto, N	1
Shimizu, H	5
Tie, D	1
Yoshida, T	2
Chinuki, Y	1
Da, X	1
Ishikawa, N	1
Morita, E	1
Wojnarowska, F	13
Kirtschig, G	10
Mason, J	3
Childs, M	3
Whitham, D	4
Harman, K	4
Chapman, A	5
Walton, S	5
Schmidt, E	7
Godec, TR	2
Nunn, AJ	7
Williams, HC	10
Watanabe, T	1
Hara, S	1
Muto, J	2
Watanabe, D	2
Akiyama, M	4
Shiba-Tokuchi, K	1
Moriuchi, R	1
Morita, Y	1
Takashima, Y	1
Shirato, T	1
Koike, Y	1
Nishie, W	3
Shimizu, S	1
Mason, JM	2
Godec, T	1
Batchelor, JM	1
Craig, FE	1
Martin-Clavijo, A	1
Ormerod, AD	1
Mizawa, M	1
Makino, T	1
Hayashi, M	1
Furukawa, F	2
Shimizu, T	1
Cardones, AR	1
Hall, RP	1
Narita, YM	1
Horie, C	1
Hirahara, K	1
Kano, Y	1
Shiohara, T	1
Mizukawa, Y	1
Liu, RC	1
Sebaratnam, DF	1
Nakama, K	1
Koga, H	2
Ishii, N	9
Ohata, C	1
Nakama, T	3
Anastasopoulou, A	1
Papaxoinis, G	1
Diamantopoulos, P	1
Christofidou, E	1
Benopoulou, O	1
Gogas, H	1
Miyashita, K	1
Iioka, H	1
Miyagawa, F	1
Asada, H	1
Sach, T	1
Holtsche, MM	1
Goletz, S	1
van Beek, N	2
Zillikens, D	5
Benoit, S	2
English, J	1
Sticherling, M	2
Levell, NJ	1
Groves, R	1
König, IR	1
Hioki, T	1
Shibata, A	1
Makita, S	1
Oka, T	1
Miyagaki, T	1
Isomura, S	1
Ichimura, Y	1
Kamata, M	1
Mitsui, H	1
Sato, S	1
Noguchi, E	1
Kamiya, K	2
Maekawa, T	1
Komine, M	1
Murata, S	2
Ohtsuki, M	1
Hübner, F	1
Kasperkiewicz, M	2
Knuth-Rehr, D	1
Shimanovich, I	1
Hübner, J	1
Süfke, S	1
Muck, P	1
Hattori, M	1
Shimizu, A	1
Ishikawa, O	1
Iwakura, R	1
Oiso, N	1
Tateishi, C	1
Suzuki, M	2
Uchida, S	1
Yanagihara, S	1
Tsuruta, D	2
Kawada, A	1
Cruz, MJ	1
Santos, P	1
Morais, P	1
Barreto, F	1
Azevedo, F	1
Wang, TS	1
Tsai, TF	1
Raffin, D	1
Delaplace, M	1
Roussel, A	1
Estève, E	1
Chuah, SY	1
Tan, SH	2
Chua, SH	2
Tang, MB	1
Lim, YL	1
Neoh, CY	1
Tan, AW	1
Kalkoff, E	1
Fahrig, A	1
Marsch, W	1
Kreft, B	1
Schulze, F	1
Meier, M	1
Nitschke, M	1
Marovt, M	1
El Shabrawi-Caelen, L	1
Bratton, DJ	3
Foster, KA	1
Ugajin, T	1
Takahashi, M	2
Miyagishi, C	1
Takayama, K	1
Yokozeki, H	1
Burden-Teh, E	1
Hofmann, SC	1
Madsen, JO	1
Lauritzen, AF	1
Lei, U	1
Maki, N	1
Demitsu, T	2
Umemoto, N	1
Nagashima, K	1
Nakamura, T	1
Kakurai, M	2
Nakamura, S	1
Yamada, T	2
Williams, A	1
Whitley-Williams, P	1
Cha, J	1
Pappert, A	1
Murphy, B	1
Walsh, M	2
McKenna, K	1
Kimura, K	1
Mishima, H	1
Komaya, K	1
Saito, T	2
Ando, K	1
Ishiguro, S	1
Ohashi, N	1
Arikawa, T	1
Komatsu, S	1
Miyachi, M	1
Sano, T	1
Aoyama, Y	2
Nishio, E	1
Horio, A	1
Tokura, Y	1
Kubin, ME	1
Hägg, PM	1
Kokkonen, N	1
Haapasaari, KM	1
Väyrynen, JP	1
Uchida, T	1
Glumoff, V	1
Kulmala, P	1
Hurskainen, T	1
Tasanen, K	1
Yamashita, C	1
Nakamizo, S	1
Honda, Y	1
Dainichi, T	1
Kabashima, K	1
Nakamura, Y	1
Kakiuti, K	1
Tani, H	1
Nakajima, H	1
Kimura, F	1
Hanafusa, T	2
Balakirski, G	1
Alkhateeb, A	1
Merk, HF	1
Leverkus, M	1
Megahed, M	1
Kabuto, M	1
Fujimoto, N	1
Takahashi, T	1
Tanaka, T	1
Mandelin, J	1
Santti, K	1
Jeskanen, L	1
Nuutinen, P	1
Amagai, M	4
Ikeda, S	3
Mizuashi, M	1
Fujisawa, A	1
Ihn, H	1
Matsuzaki, Y	1
Ohtsuka, M	1
Fujiwara, H	2
Furuta, J	1
Tago, O	1
Yamagami, J	1
Tanikawa, A	1
Uhara, H	2
Morita, A	1
Nakanishi, G	1
Tani, M	1
Makino, E	1
Muto, M	1
Manabe, M	1
Konno, T	1
Izaki, S	2
Watanabe, H	1
Yamaguchi, Y	1
Matsukura, S	1
Seishima, M	1
Habe, K	1
Yoshida, Y	1
Kaneko, S	1
Shindo, H	1
Nakajima, K	1
Kanekura, T	4
Takahashi, K	1
Kitajima, Y	2
Hashimoto, K	1
Kawahira, H	1
Higashi, Y	1
Matsuoka, A	1
Fujii, K	1
Orime, M	1
Tomiyama, K	1
Hashidate, H	1
Yoshida, S	1
Hokari, S	1
Tsuda, A	1
Yokoyama, H	1
Narita, JI	1
Uchida, Y	1
Kawai, K	2
Lin, SS	1
Wang, KH	1
Yeh, SW	1
Chen, WY	1
Tsai, TH	1
Harada, S	1
Hatakeyama, S	1
Kitazawa, T	1
Itoyama, S	1
Ota, Y	1
Koike, K	1
Hamada, T	2
Ohyama, B	2
Yasumoto, S	2
Twine, CP	1
Malik, G	1
Street, S	1
Williams, IM	1
McCourt, C	1
Corry, A	1
McMillan, C	1
Majmudar, V	1
Herath, D	1
O'Toole, EA	1
Harrison, A	1
Pérez, A	1
Almaani, N	1
Stefanato, CM	1
BhogaL, B	2
Groves, RW	1
Mellerio, JE	1
McGrath, JA	1
Umekoji, A	1
Inoue, T	1
Nishimori, T	1
Ishii, M	1
Yamaki, F	1
Mayuzumi, N	1
Kaminaka, C	1
Kanazawa, N	1
Shiohara, J	1
Yoshida, K	1
Hasegawa, J	1
Takata, M	1
Saida, T	1
Oyama, B	1
Gharami, RC	1
Kumar, P	1
Mondal, A	1
Ghosh, K	1
Middleton, P	3
Bennett, C	1
Murrell, DF	2
Khumalo, NP	2
Hafiji, J	1
Rytina, E	1
Burrows, NP	1
Bain, S	1
Ball, L	1
Kusajima, E	1
Sato, M	1
Natsuga, K	2
Miida, H	1
Ito, M	1
Park, KY	1
Kim, BJ	1
Kim, MN	1
Kulthanan, K	2
Chularojanamontri, L	1
Tuchinda, P	1
Sirikudta, W	1
Pinkaew, S	1
Kikuchi, K	1
Shinkuma, S	1
Kajita, S	1
Sato, H	1
Tee, SI	1
Yosipovitch, G	1
Chan, YC	1
Koh, ET	1
Chan, YH	1
Tan, SS	1
Tsou, IY	1
Sakanoue, M	1
Sandell, A	1
Müller, PA	1
Bröcker, EB	2
Klinker, E	1
Stoevesandt, J	1
Sugiura, K	1
Sugiura, N	1
Yagi, T	1
Iguchi, M	1
Ohno, H	1
Miyazaki, Y	1
Kahan, BC	1
Phillips, PP	1
Zaraa, I	1
Mahfoudh, A	1
Sellami, MK	1
Chelly, I	1
El Euch, D	1
Zitouna, M	1
Mokni, M	1
Makni, S	1
Ben Osman, A	1
Ekiz, Ö	1
Şen, BB	1
Rifaioğlu, EN	1
Özgür, T	1
İnan, MU	1
Doğramacı, ÇA	1
Ardern-Jones, MR	2
Venning, VA	2
Zachariae, CO	1
Calikoglu, E	1
Anadolu, R	1
Erdem, C	1
Calikoglu, T	1
Nomura, A	1
Fujisawa, H	2
Sekizawa, K	1
Khumalo, N	2
Hollis, S	2
Murrell, D	2
James, MP	1
Izumi, T	1
Ichiki, Y	1
Esaki, C	1
Kim, YJ	1
Kim, MY	1
Kim, HO	1
Park, YM	1
Furukawa, H	1
Miura, T	1
Nakamura, K	1
Kaneko, F	1
Ishii, F	1
Komai, R	1
Chave, TA	1
Mortimer, NJ	1
Shah, DS	1
Hutchinson, PE	2
Shimizu, K	1
Ogawa, F	1
Hamasaki, Y	1
Murota, H	1
Katayama, I	1
Nanda, A	2
Al-Saeid, K	1
Al-Sabah, H	2
Dvorak, R	2
Alsaleh, QA	2
Maeda, JY	1
Moura, AK	1
Maruta, CW	1
Santi, CG	1
Prisayanh, PS	1
Aoki, V	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
An Open Randomized Comparative Trial of Four Different Dressings for Cutaneous Coverage in Pemphigus and Pemphigoid[NCT02365675]		12 participants (Anticipated)	Interventional	2015-01-31	Recruiting
Rituximab in the Treatment of Patients With Bullous Pemphigoid[NCT00286325]	Phase 1/Phase 2	8 participants (Actual)	Interventional	2005-03-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Peripheral blood B cell number at week 24 compared to B cell number at week 0 (NCT00286325)
Timeframe: Week 0 and at 24 weeks

IgG Anti Bullous Pemphigoid (BP) 180 Measured in Units by ELISA at Week 24.

Intervention	B cells per microliter (Median)
Treated	3.99

IgG antibodies against BP 180 measured in units (by ELISA) for each participant at week 0 compared to value at week 24, (NCT00286325)
Timeframe: Week 0 and at 24 weeks

Number of Days to Cessation of New Blister

Intervention	Elisa Units (Median)
Treated	40.5

The first study visit in which patient reported and was confirmed to have no new blister or lesion formation . (NCT00286325)
Timeframe: 1 year

Systemic Corticosteroid Dose of 25% of Starting Dose or 10 mg/Day by Week 24

Intervention	Days (Median)
Treated	57

Subject systemic corticosteroid dosage at week 24 was 25% of starting dose or 10 mg/day of prednisone or less (NCT00286325)
Timeframe: 24 weeks

Primary Safety Endpoint

Intervention	participants (Number)
Treated	7

The primary safety endpoint is the occurrence of treatment emergent adverse events including infections, infusion reactions and disease progression. These were determined by clinical evaluation and laboratory questions. Disease progression is defined as development of new blisters despite therapy. These are reported as the number of participants with a study related SAE. (NCT00286325)
Timeframe: 1 year

Article	Year
Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review. Frontiers in immunology, 2022, Volume: 13 Topics: Autoantibodies; Blister; Humans; Laminin; Middle Aged; Pemphigoid, Bullous; Prednisolone; Psoriasis	2022
Bullous pemphigoid complicated by cytomegalovirus disease as a manifestation of immune reconstitution inflammatory syndrome: retrospective analyses of our institutional cases and literature review. International journal of dermatology, 2018, Volume: 57, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cytomegalovirus Infections; Fatal Outcome;	2018
Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature. Journal of immunotherapy (Hagerstown, Md. : 1997), 2018, Volume: 41, Issue:3 Topics: Antineoplastic Agents, Immunological; Eosinophilia; Humans; Immunoglobulin E; Lymph Nodes; Male; Mel	2018
Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:10 Topics: Adult; Female; Humans; Male; Middle Aged; Omalizumab; Pemphigoid, Bullous; Prednisolone	2016
Interventions for bullous pemphigoid. The Cochrane database of systematic reviews, 2010, Oct-06, Issue:10 Topics: Azathioprine; Clobetasol; Combined Modality Therapy; Drug Therapy, Combination; Drugs, Chinese Herba	2010
Lichen planus pemphigoides: four new cases and a review of the literature. International journal of dermatology, 2013, Volume: 52, Issue:4 Topics: Anti-Inflammatory Agents; Basement Membrane; Complement C3; Female; Humans; Immunoglobulin G; Lichen	2013
Interventions for bullous pemphigoid. The Cochrane database of systematic reviews, 2003, Issue:3 Topics: Azathioprine; Glucocorticoids; Humans; Immunosuppressive Agents; Niacinamide; Pemphigoid, Bullous; P	2003
Interventions for bullous pemphigoid. The Cochrane database of systematic reviews, 2005, Jul-20, Issue:3 Topics: Azathioprine; Glucocorticoids; Humans; Immunosuppressive Agents; Niacinamide; Pemphigoid, Bullous; P	2005
Pemphigus and pemphigoid in dog and man: comparative aspects. Journal of the American Academy of Dermatology, 1981, Volume: 5, Issue:2 Topics: Animals; Aurothioglucose; Dapsone; Dog Diseases; Dogs; Fluorescent Antibody Technique; Humans; Mouth	1981
Bilateral inguinal scrofuloderma during steroid therapy in a patient with bullous pemphigoid. The Journal of dermatology, 1995, Volume: 22, Issue:8 Topics: Aged; Anti-Inflammatory Agents; Female; Glucocorticoids; Groin; Humans; Immunocompromised Host; Ingu	1995
[A case of resected lung cancer associated with bullous pemphigoid]. [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1996, Volume: 44, Issue:4 Topics: Adenocarcinoma; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Pemphigoid, Bullous;	1996
Bullous pemphigoid--management of a patient with oral and skin lesions. Singapore dental journal, 1994, Volume: 19, Issue:1 Topics: Administration, Topical; Anti-Inflammatory Agents; Biopsy; Carboxymethylcellulose Sodium; Drug Thera	1994
[Bullous pemphigoid]. Ryoikibetsu shokogun shirizu, 2000, Issue:31 Topics: Autoantibodies; Autoantigens; Carrier Proteins; Collagen; Collagen Type XVII; Cytoskeletal Proteins;	2000
A systematic review of treatments for bullous pemphigoid. Archives of dermatology, 2002, Volume: 138, Issue:3 Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans;	2002
A systematic review of treatments for bullous pemphigoid. Archives of dermatology, 2002, Volume: 138, Issue:3 Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans;	2002
A systematic review of treatments for bullous pemphigoid. Archives of dermatology, 2002, Volume: 138, Issue:3 Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans;	2002
A systematic review of treatments for bullous pemphigoid. Archives of dermatology, 2002, Volume: 138, Issue:3 Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans;	2002

Article	Year
A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracycl Health technology assessment (Winchester, England), 2017, Volume: 21, Issue:10 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cost-Benefit Analysis;	2017
Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial. The British journal of dermatology, 2018, Volume: 178, Issue:2 Topics: Aged; Cost-Benefit Analysis; Dermatologic Agents; Doxycycline; Female; Health Status; Humans; Male;	2018
Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score. The British journal of dermatology, 2018, Volume: 179, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Collagen Type XVII; Doxycycline; Femal	2018
A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines The British journal of dermatology, 2015, Volume: 173, Issue:1 Topics: Administration, Oral; Dermatologic Agents; Doxycycline; Drug Administration Schedule; Humans; Pemphi	2015
A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid. Journal of dermatological science, 2017, Volume: 85, Issue:2 Topics: Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Collagen Type XVII; Double-Blind Method; Drug	2017
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet (London, England), 2017, 04-22, Volume: 389, Issue:10079 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clinical Trials as Topi	2017
Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study. Archives of dermatology, 2012, Volume: 148, Issue:3 Topics: Administration, Oral; Adult; Alendronate; Anti-Inflammatory Agents; Autoimmune Diseases; Bone Densit	2012
Efficacy of interferon-gamma in patients with refractory bullous pemphigoid. The Journal of dermatology, 2007, Volume: 34, Issue:11 Topics: Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Collagen Type XVII; Cytokines; Drug Therapy,	2007
Plasma exchange in bullous pemphigoid. Lancet (London, England), 1984, Sep-01, Volume: 2, Issue:8401 Topics: Aged; Autoantibodies; Basement Membrane; Clinical Trials as Topic; Female; Humans; Male; Pemphigoid,	1984
[Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study]. Annales de dermatologie et de venereologie, 1984, Volume: 111, Issue:10 Topics: Aged; Clinical Trials as Topic; Female; Humans; Male; Pemphigoid, Bullous; Prednisolone; Random Allo	1984
[Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study]. Annales de dermatologie et de venereologie, 1993, Volume: 120, Issue:8 Topics: Administration, Oral; Aged; Aged, 80 and over; Female; Humans; Male; Methylprednisolone; Pemphigoid,	1993
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Archives of dermatology, 1993, Volume: 129, Issue:9 Topics: Azathioprine; Combined Modality Therapy; Humans; Methyltransferases; Pemphigoid, Bullous; Plasma Exc	1993
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Archives of dermatology, 1993, Volume: 129, Issue:1 Topics: Aged; Azathioprine; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Pemp	1993
Prednisone is more effective than prednisolone metasulfobenzoate in the treatment of bullous pemphigoid. Archives of dermatology, 1999, Volume: 135, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Male; Middle Aged; Pemphigoid, Bull	1999
Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Archives of dermatology, 2000, Volume: 136, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Aut	2000
Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment. Journal of the American Academy of Dermatology, 2001, Volume: 45, Issue:6 Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppre	2001
Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients. International journal of clinical pharmacology, therapy, and toxicology, 1991, Volume: 29, Issue:9 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Female;	1991
Long term plasma exchange therapy in bullous pemphigoid. Acta dermato-venereologica, 1986, Volume: 66, Issue:1 Topics: Aged; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pemphigoid, Bullous; Plasma Exch	1986

Article	Year
Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid showing positive autoantibody responses to multiple epitopes. Journal of dermatological science, 2021, Volume: 103, Issue:3 Topics: Autoantibodies; Autoantigens; Collagen Type XVII; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV	2021
Long-term oral prednisolone exposure in primary care for bullous pemphigoid: population-based study. The British journal of general practice : the journal of the Royal College of General Practitioners, 2021, Volume: 71, Issue:713 Topics: Adult; Aged; Glucocorticoids; Humans; Pemphigoid, Bullous; Prednisolone; Primary Health Care; Prospe	2021
Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients: New evidence for the safety of rituximab. Dermatologic therapy, 2022, Volume: 35, Issue:11 Topics: Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Pemphigoid, Bullous; Pemphigus; Predniso	2022
A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma. The Journal of dermatology, 2023, Volume: 50, Issue:9 Topics: Antibodies, Monoclonal; Asthma; Blister; Humans; Pemphigoid, Bullous; Prednisolone; Pulmonary Eosino	2023
Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid. Frontiers in immunology, 2023, Volume: 14 Topics: Glucocorticoids; Humans; Pemphigoid, Bullous; Prednisolone; Recurrence; Retrospective Studies; Stero	2023
Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid, likely triggered by scabies, in a hemodialysis patient with human leukocyte antigen-DQB103:01. CEN case reports, 2020, Volume: 9, Issue:3* Topics: Alleles; Autoantibodies; Biopsy; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Gluc	2020
Bullous Pemphigoid in Three Paediatric Patients in Finland. Acta dermato-venereologica, 2020, Mar-18, Volume: 100, Issue:6 Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Autoantibodies; Autoantigens; Child,	2020
Refractory Bullous Pemphigoid Improved by Discontinuation of Phenytoin as an CYP3A4 Inducer. Acta dermato-venereologica, 2020, 04-06, Volume: 100, Issue:8 Topics: Aged; Anti-Inflammatory Agents; Anticonvulsants; Cerebral Palsy; Cytochrome P-450 CYP3A Inducers; Dr	2020
Management of immune checkpoint inhibitor-induced bullous pemphigoid. Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:2 Topics: Administration, Cutaneous; Administration, Oral; Dose-Response Relationship, Drug; Glucocorticoids;	2021
Dermpath & Clinic: Lichen planus pemphigoides. European journal of dermatology : EJD, 2020, Apr-01, Volume: 30, Issue:2 Topics: Biopsy; Dapsone; Dermatologic Agents; Diagnosis, Differential; Glucocorticoids; Humans; Immunosuppre	2020
Bullous pemphigoid is a common associated disorder with acquired haemophilia A. International journal of hematology, 2021, Volume: 113, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibodies; Cyclophosphamide; Factor VIII; Fem	2021
Diagnosis and treatment of bullous pemphigoid that developed twice after total knee replacement arthroplasty: a case report. BMC musculoskeletal disorders, 2021, Jan-28, Volume: 22, Issue:1 Topics: Aged; Arthroplasty, Replacement, Knee; Humans; Knee Prosthesis; Male; Pemphigoid, Bullous; Prednisol	2021
Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in England. BMC medical research methodology, 2021, 02-04, Volume: 21, Issue:1 Topics: Electronic Health Records; England; Feasibility Studies; Humans; Pemphigoid, Bullous; Prednisolone	2021
Clinical characteristics and outcomes of bullous pemphigoid patients with versus without oral prednisolone treatment. The Journal of dermatology, 2021, Volume: 48, Issue:4 Topics: Aged; Erythema; Humans; Pemphigoid, Bullous; Prednisolone; Retrospective Studies; Urticaria	2021
Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies. The Journal of dermatology, 2017, Volume: 44, Issue:7 Topics: Administration, Cutaneous; Aged; Autoantibodies; Autoantigens; Biopsy; Collagen Type XVII; Complemen	2017
Infantile bullous pemphigoid successfully treated with intravenous immunoglobulin therapy. Clinical and experimental dermatology, 2017, Volume: 42, Issue:5 Topics: Drug Resistance; Eosinophils; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulins, Intravenou	2017
Case of bullous pemphigoid accompanied by collagenous gastroenteritis. The Journal of dermatology, 2017, Volume: 44, Issue:12 Topics: Biopsy; Collagen; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent An	2017
Generating new evidence, improving clinical practice and developing research capacity: the benefits of recruiting to the U.K. Dermatology Clinical Trials Network's STOP GAP and BLISTER trials. The British journal of dermatology, 2017, Volume: 177, Issue:5 Topics: Adrenal Cortex Hormones; Attitude of Health Personnel; Cyclosporine; Dermatologists; Doxycycline; Ev	2017
A case of lichen planus pemphigoides with palmoplantar keratoderma. European journal of dermatology : EJD, 2018, 02-01, Volume: 28, Issue:1 Topics: Anti-Inflammatory Agents; Female; Foot Dermatoses; Hand Dermatoses; Humans; Lichen Planus; Middle Ag	2018
Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients? The British journal of dermatology, 2017, Volume: 177, Issue:5 Topics: Anti-Bacterial Agents; Doxycycline; Humans; Pemphigoid, Bullous; Prednisolone	2017
The need for longer time horizons for cost-utility evaluation in bullous pemphigoid: reply from the authors. The British journal of dermatology, 2018, Volume: 178, Issue:3 Topics: Cost-Benefit Analysis; Doxycycline; Humans; Pemphigoid, Bullous; Prednisolone	2018
The need for longer time horizons for cost-utility evaluation in bullous pemphigoid. The British journal of dermatology, 2018, Volume: 178, Issue:3 Topics: Cost-Benefit Analysis; Doxycycline; Humans; Pemphigoid, Bullous; Prednisolone	2018
Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain. JAMA dermatology, 2018, 03-01, Volume: 154, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Autoantibodies; Autoantigens; Collagen Type XVII;	2018
A case of bullous pemphigoid with IgG antibodies against LAD-1, but not BP180 NC16a domain or BP230. European journal of dermatology : EJD, 2018, 04-01, Volume: 28, Issue:2 Topics: Aged; Autoantibodies; Autoantigens; Biopsy, Needle; Collagen Type XVII; Dystonin; Enzyme-Linked Immu	2018
Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid. The British journal of dermatology, 2018, Volume: 178, Issue:2 Topics: Cost-Benefit Analysis; Doxycycline; Humans; Pemphigoid, Bullous; Prednisolone; Quality-Adjusted Life	2018
Dyshidrosiform pemphigoid restricted to the soles. International journal of dermatology, 2018, Volume: 57, Issue:6 Topics: Aged, 80 and over; Anti-Inflammatory Agents; Autoantibodies; Autoantigens; Collagen Type XVII; Femal	2018
Linear immunoglobulin A bullous dermatosis limited to oral mucosa associated with ulcerative colitis. The Journal of dermatology, 2018, Volume: 45, Issue:10 Topics: Administration, Oral; Biopsy; Colitis, Ulcerative; Colon; Colonoscopy; Diagnosis, Differential; Huma	2018
Bullous pemphigoid complicated by necrotising fasciitis successfully treated with systemic corticosteroids and antibiotics in combination with i.v. immunoglobulin. The Australasian journal of dermatology, 2018, Volume: 59, Issue:4 Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Fasciitis, Necrotizing; Female; Humans; Immun	2018
Adjuvant treatment of severe/refractory bullous pemphigoid with protein A immunoadsorption. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2018, Volume: 16, Issue:9 Topics: Aged; Aged, 80 and over; Antimalarials; Autoantibodies; Clobetasol; Dapsone; Female; Glucocorticoids	2018
Development of pemphigoid nodularis after remission of bullous lesions. Clinical and experimental dermatology, 2019, Volume: 44, Issue:2 Topics: Aged; Anti-Infective Agents; Dapsone; Female; Glucocorticoids; Humans; Methylprednisolone; Pemphigoi	2019
Pemphigus foliaceus progressing to bullous pemphigoid. The Journal of dermatology, 2019, Volume: 46, Issue:11 Topics: Aged, 80 and over; Biopsy; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunoglo	2019
Refractory bullous pemphigoid with fatal outcome in a young patient. International journal of dermatology, 2013, Volume: 52, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Drug Resistan	2013
Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate. Acta dermato-venereologica, 2014, Volume: 94, Issue:1 Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, C	2014
[Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)]. Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:12 Topics: Aged; Autoantibodies; Autoantigens; Clobetasol; Dapsone; Drug Resistance; Humans; Immunoglobulin G;	2013
A retrospective review of the therapeutic response with remission in patients with newly diagnosed bullous pemphigoid. The Australasian journal of dermatology, 2014, Volume: 55, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Child;	2014
Bullous eruption on the back of both hands in a newborn. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2014, Volume: 12, Issue:7 Topics: Administration, Oral; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Hand Dermatoses; Hu	2014
Treatment of bullous pemphigoid with adjuvant immunoadsorption: a case series. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents; Autoantibodies; Dapsone; F	2014
Purpuric bullous pemphigoid. The American Journal of dermatopathology, 2015, Volume: 37, Issue:2 Topics: Aged, 80 and over; Biopsy; Dapsone; Diagnosis, Differential; Drug Administration Schedule; Drug Ther	2015
A case of bullous pemphigoid associated with infiltration and activation of basophils. The British journal of dermatology, 2015, Volume: 173, Issue:4 Topics: Adult; Basophils; Dermatologic Agents; Female; Humans; Immunoglobulin G; Pemphigoid, Bullous; Phosph	2015
What is a pragmatic clinical trial? The Journal of investigative dermatology, 2015, Volume: 135, Issue:6 Topics: Cost-Benefit Analysis; Doxycycline; Humans; Pemphigoid, Bullous; Pragmatic Clinical Trials as Topic;	2015
Doxycycline in the treatment of bullous pemphigoid: as good as systemic corticosteroids? The British journal of dermatology, 2015, Volume: 173, Issue:1 Topics: Dermatologic Agents; Doxycycline; Humans; Pemphigoid, Bullous; Prednisolone	2015
[Bullous pemphigoid may also be seen in children]. Ugeskrift for laeger, 2015, Sep-28, Volume: 177, Issue:40 Topics: Glucocorticoids; Humans; Infant; Male; Pemphigoid, Bullous; Prednisolone	2015
Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia. The Journal of dermatology, 2016, Volume: 43, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoantigens; Biopsy; Collagen Type	2016
A Case of Bullous Pemphigoid in an Infant. Clinical pediatrics, 2016, Volume: 55, Issue:6 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biopsy; Clindamycin; Diagnosis, Differential; Femal	2016
Bullous Pemphigoid Arising in Lower Leg Vein Graft Incision Site. Journal of cardiac surgery, 2016, Volume: 31, Issue:1 Topics: Cicatrix; Coronary Artery Bypass; Diphosphonates; Humans; Lower Extremity; Male; Middle Aged; Pemphi	2016
[A Case of Bullous Pemphigoid Relieved after Sigmoid Colon Cancer Resection]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Adenocarcinoma; Aged; Anti-Inflammatory Agents; Humans; Male; Pemphigoid, Bullous; Prednisolone; Sig	2015
Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis. The Journal of dermatology, 2016, Volume: 43, Issue:9 Topics: Administration, Oral; Anti-Bacterial Agents; Autoantigens; Chemokine CCL17; Collagen Type XVII; Comp	2016
Expression of Glucocorticoid Receptors GRα and GRβ in Bullous Pemphigoid. Acta dermato-venereologica, 2016, Nov-02, Volume: 96, Issue:7 Topics: Biopsy; Blotting, Western; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Flow Cyt	2016
Combination therapy of prednisolone and i.v. immunoglobulin treatment decreases circulating interleukin-5 and eosinophils in a patient with bullous pemphigoid. The Journal of dermatology, 2017, Volume: 44, Issue:1 Topics: Administration, Intravenous; Autoantibodies; Autoantigens; Azathioprine; Biopsy; Collagen Type XVII;	2017
Herpes simplex encephalitis without cerebrospinal fluid pleocytosis in a patient with bullous pemphigoid: a case report. Rinsho shinkeigaku = Clinical neurology, 2016, 06-22, Volume: 56, Issue:6 Topics: Acyclovir; Administration, Oral; Aged; Antiviral Agents; Biomarkers; Cerebrospinal Fluid; DNA, Viral	2016
Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid. The British journal of dermatology, 2017, Volume: 176, Issue:5 Topics: Antigens, CD; B-Lymphocytes, Regulatory; Female; Glucocorticoids; Humans; Immunosuppressive Agents;	2017
Bullous pemphigoid triggered by radiotherapy for breast cancer. Presse medicale (Paris, France : 1983), 2017, Volume: 46, Issue:1 Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Pemphigoid, Bullous; Prednisolone	2017
Pyodermatitis vegetans with antibodies to bullous pemphigoid antigen 180. The Journal of dermatology, 2017, Volume: 44, Issue:12 Topics: Autoantibodies; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Humans; Male; Middle Aged; Pemph	2017
Non-paraneoplastic autoimmune subepidermal bullous disease associated with fatal bronchiolitis obliterans. The Journal of dermatology, 2017, Volume: 44, Issue:4 Topics: Aged; Anti-Bacterial Agents; Autoantibodies; Autoantigens; Basement Membrane; Biopsy; Bronchiolitis	2017
Simultaneous occurrence of pemphigus foliaceus and bullous pemphigoid with concomitant herpesvirus infection. Clinical and experimental dermatology, 2009, Volume: 34, Issue:4 Topics: Aged; Glucocorticoids; Herpes Genitalis; Herpesvirus 2, Human; Humans; Male; Pemphigoid, Bullous; Pe	2009
[A case of disseminated nocardiosis followed by pneumocystis pneumonia in a patient prescribed corticosteroid and cyclosporin A and having elevated blood (1-->3)-beta-D-glucan]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2009, Volume: 83, Issue:5 Topics: Aged; beta-Glucans; Cyclosporine; Humans; Male; Nocardia Infections; Opportunistic Infections; Pemph	2009
An association of idiopathic chronic eosinophilic pneumonia with pemphigoid nodularis: a rare variant of bullous pemphigoid. Archives of dermatology, 2009, Volume: 145, Issue:11 Topics: Aged; Biopsy, Needle; Chronic Disease; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; F	2009
Bullous pemphigoid presenting as dry gangrene in a revascularized limb. Journal of vascular surgery, 2010, Volume: 51, Issue:3 Topics: Aged; Anti-Bacterial Agents; Arterial Occlusive Diseases; Biopsy; Blood Vessel Prosthesis Implantati	2010
Generalized pruritic eruption in a patient with chronic kidney disease. Dermatology online journal, 2010, Apr-15, Volume: 16, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Chronic Disease; Humans; Kidney Diseases; Male; Pemphigoid, Bullous;	2010
Bullous pemphigoid of childhood: a rare disease with diagnostic and management challenges. Clinical and experimental dermatology, 2010, Volume: 35, Issue:2 Topics: Anti-Inflammatory Agents; Drug Combinations; Erythromycin; Female; Genetic Predisposition to Disease	2010
Bullous pemphigoid in a patient with suspected non-Herlitz junctional epidermolysis bullosa. Clinical and experimental dermatology, 2010, Volume: 35, Issue:8 Topics: Autoantigens; Blister; Brain Neoplasms; Collagen Type XVII; Dental Enamel Hypoplasia; Eosinophils; E	2010
Bullous pemphigoid as a dermadrome associated with spindle cell carcinoma of the gallbladder. The Journal of dermatology, 2010, Volume: 37, Issue:3 Topics: Aged, 80 and over; Carcinoma; Cholecystectomy, Laparoscopic; Eosinophilia; Fatal Outcome; Gallbladde	2010
Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid. The Journal of dermatology, 2010, Volume: 37, Issue:3 Topics: Aged, 80 and over; Autoantibodies; Basement Membrane; Dapsone; Desmoglein 1; Female; Humans; Immunog	2010
Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma. The Journal of dermatology, 2010, Volume: 37, Issue:3 Topics: Autoantibodies; Cyclosporine; Dermatitis, Exfoliative; Humans; Immunoglobulin G; Laminin; Male; Midd	2010
Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist. The Journal of dermatology, 2010, Volume: 37, Issue:7 Topics: Autoantigens; Collagen Type XVII; Desmoglein 1; Drug Therapy, Combination; Female; Humans; Middle Ag	2010
Dyshidrosiform Pemphigus vulgaris: Report of an unusual case. Dermatology online journal, 2010, Jul-15, Volume: 16, Issue:7 Topics: Adult; Blister; Cyclophosphamide; Eczema, Dyshidrotic; Female; Foot Dermatoses; Humans; Immunoglobul	2010
Bullous pemphigoid in infancy developing after the first vaccination. Clinical and experimental dermatology, 2010, Volume: 35, Issue:8 Topics: Diphtheria; Glucocorticoids; Haemophilus Infections; Heptavalent Pneumococcal Conjugate Vaccine; Hum	2010
Physical signs for the general dental practitioner. Case 78. Bullous pemphigoid. Dental update, 2010, Volume: 37, Issue:8 Topics: Aged; Anti-Inflammatory Agents; Autoantibodies; Humans; Immunosuppressive Agents; Male; Pemphigoid,	2010
Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission. International journal of dermatology, 2011, Volume: 50, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Azathioprine; Cohort Studies; Collagen	2011
Association between effective dose of prednisolone, alone or in conjunction with other immunosuppressants, and titre of anti-bullous pemphigoid 180 antibody: a retrospective study of 42 cases. Clinical and experimental dermatology, 2011, Volume: 36, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Biomarkers; Collagen Type XVII; Dose-R	2011
Amlodipine-associated bullous pemphigoid with erythema multiforme-like clinical features. International journal of dermatology, 2011, Volume: 50, Issue:5 Topics: Aged, 80 and over; Amlodipine; Anti-Inflammatory Agents; Calcium Channel Blockers; Erythema Multifor	2011
Prevalence and clinical features of Thai patients with bullous pemphigoid. Asian Pacific journal of allergy and immunology, 2011, Volume: 29, Issue:1 Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Female; Humans; Male; Middle Aged; Neoplasms; Nervous	2011
Subepidermal blistering disease with 3 distinct autoantibodies: anti-BP230, anti-laminin gamma-1, and anti-laminin-332. Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:4 Topics: Adult; Autoantibodies; Basement Membrane; Carrier Proteins; Cell Adhesion Molecules; Cytoskeletal Pr	2011
Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil. The Journal of dermatology, 2012, Volume: 39, Issue:10 Topics: Cyclosporine; Dermatologic Agents; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Hum	2012
The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study. Trials, 2012, Apr-27, Volume: 13 Topics: Bias; Decision Support Techniques; Dermatologic Agents; Doxycycline; Endpoint Determination; Humans;	2012
Adjuvant treatment of recalcitrant bullous pemphigoid with immunoadsorption. Dermatology (Basel, Switzerland), 2012, Volume: 224, Issue:3 Topics: Adjuvants, Immunologic; Autoantibodies; Autoantigens; Carrier Proteins; Collagen Type XVII; Cytoskel	2012
Cryptococcal cellulitis in a patient with bullous pemphigoid. Acta dermato-venereologica, 2013, Mar-27, Volume: 93, Issue:2 Topics: Aged; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Glucoc	2013
When inferiority meets non-inferiority: implications for interim analyses. Clinical trials (London, England), 2012, Volume: 9, Issue:5 Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Computer Simulation; Doxycycline; Humans; Models, St	2012
Necrotizing fasciitis in a patient with bullous pemphigoid treating with systemic steroid. Cutaneous and ocular toxicology, 2013, Volume: 32, Issue:3 Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Fasciitis, Necrotizing; Female; Humans; Pemph	2013
Oral and topical corticosteroids in bullous pemphigoid. The New England journal of medicine, 2002, Jul-11, Volume: 347, Issue:2 Topics: Administration, Oral; Administration, Topical; Glucocorticoids; Humans; Pemphigoid, Bullous; Prednis	2002
Gabapentin-induced bullous pemphigoid. Acta dermato-venereologica, 2002, Volume: 82, Issue:5 Topics: Acetates; Amines; Anticonvulsants; Azathioprine; Cyclohexanecarboxylic Acids; Drug Therapy, Combinat	2002
Localized bullous pemphigoid as an unusual complication of radiation therapy. Journal of the European Academy of Dermatology and Venereology : JEADV, 2002, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Pemphigoid, Bullous; Prednisolone; Radiot	2002
Treatment of bullous pemphigoid with a leukotriene receptor antagonist. Allergy, 2003, Volume: 58, Issue:2 Topics: Anti-Asthmatic Agents; Asthma; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female;	2003
Blistering eruption on an elderly woman's leg--quiz case. Archives of dermatology, 2004, Volume: 140, Issue:4 Topics: Aged; Aged, 80 and over; Biopsy, Needle; Female; Follow-Up Studies; Humans; Immunohistochemistry; In	2004
Monitoring of ELISA for anti-BP180 antibodies: clinical and therapeutic analysis of steroid-treated patients with bullous pemphigoid. The Journal of dermatology, 2004, Volume: 31, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Autoantibodies; Autoantigens; Collagen Type XVII; Da	2004
Dyshidrosiform bullous pemphigoid. Acta dermato-venereologica, 2004, Volume: 84, Issue:3 Topics: Aged; Aged, 80 and over; Eczema, Dyshidrotic; Female; Foot Dermatoses; Glucocorticoids; Humans; Pemp	2004
A case of anti-p200 pemphigoid with autoantibodies against both a novel 200-kD dermal antigen and the 290-kD epidermolysis bullosa acquisita antigen. Dermatology (Basel, Switzerland), 2004, Volume: 209, Issue:2 Topics: Adult; Autoantigens; Biopsy, Needle; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; I	2004
Chlorambucil as a steroid-sparing agent in bullous pemphigoid. The British journal of dermatology, 2004, Volume: 151, Issue:5 Topics: Aged; Aged, 80 and over; Chlorambucil; Drug Therapy, Combination; Female; Glucocorticoids; Humans; M	2004
A case of bullous pemphigoid arising in juvenile hyaline fibromatosis with oral squamous cell carcinoma. The Journal of dermatology, 2005, Volume: 32, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Consanguinity; Diagnosis,	2005
Clinicoepidemiological features and course of 43 cases of bullous pemphigoid in Kuwait. Clinical and experimental dermatology, 2006, Volume: 31, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Arabs; Chi-Square Distribution; Female; Follow-Up Studies; Glucocort	2006
Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid. Clinical and experimental dermatology, 2006, Volume: 31, Issue:5 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Autoantibodies; Biopsy; Blister; Fatal Outcome; Flu	2006
A dilemma: bullous-pemphigoid-like eruption in scabies or scabies-induced bullous pemphigoid. Dermatology online journal, 2006, May-30, Volume: 12, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Complement C3; Diagnosis, Differential; Disease Susceptibility; H	2006
[A case of bullous pemphigoid associated with Pneumocystis pneumonia and Cytomegalovirus pneumonia]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:12 Topics: Aged; Anti-Inflammatory Agents; Cytomegalovirus Infections; Humans; Male; Pemphigoid, Bullous; Pneum	2006
Treatment of bullous pemphigoid with enteric-coated mycophenolate sodium. Journal of the European Academy of Dermatology and Venereology : JEADV, 2007, Volume: 21, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Complement C3; Female; Fluorescent Antibody Technique, Direct; Gluco	2007
Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone. The British journal of dermatology, 2007, Volume: 156, Issue:5 Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Dapsone; Female; Glucocorticoid	2007
Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:5 Suppl Topics: Autoantibodies; Autoantigens; Bone Marrow Transplantation; Cell Adhesion Molecules; Collagen Type XV	2007
Kaposi's sarcoma as a Köbner phenomenon in a patient with bullous pemphigoid and sarcoidosis. Clinical and experimental dermatology, 2007, Volume: 32, Issue:5 Topics: Aged; Anti-Inflammatory Agents; Humans; Male; Pemphigoid, Bullous; Prednisolone; Sarcoidosis, Pulmon	2007
Localized pemphigoid (pretibial type) with IgG antibody to BP180 NC16a domain successfully treated with minocycline and topical corticosteroid. Clinical and experimental dermatology, 2007, Volume: 32, Issue:6 Topics: Autoantibodies; Autoantigens; Collagen Type XVII; Drug Therapy, Combination; Humans; Immunoglobulin	2007
Bullous pemphigoid (BP) in an infant complicated by tuberculous meningoencephalitis. International journal of dermatology, 2007, Volume: 46, Issue:9 Topics: Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Infant;	2007
Eosinophilic spongiosis in a case of lichen sclerosus: a marker for superimposed bullous pemphigoid? Histopathology, 2008, Volume: 52, Issue:7 Topics: Aged; Azathioprine; Drug Therapy, Combination; Eosinophilia; Female; Glucocorticoids; Humans; Immuno	2008
Bullous pemphigoid in a dog: treatment with six-mercaptopurine. Journal of the American Veterinary Medical Association, 1984, Sep-15, Volume: 185, Issue:6 Topics: Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Fluorescent Antibody Technique; Humans; Male	1984
Autoimmune skin disease of large animals. The Veterinary clinics of North America. Large animal practice, 1984, Volume: 6, Issue:1 Topics: Animals; Aurothioglucose; Autoimmune Diseases; Biopsy; Diagnosis, Differential; Female; Horse Diseas	1984
Observations of the immunopathology and therapy of canine pemphigus and pemphigoid. Journal of the American Veterinary Medical Association, 1982, Jan-01, Volume: 180, Issue:1 Topics: Animals; Aurothioglucose; Cyclophosphamide; Dog Diseases; Dogs; Drug Therapy, Combination; Fluoresce	1982
Bullous pemphigoid refractory to recommended dosage of prednisolone in a dog. Journal of the American Veterinary Medical Association, 1981, Sep-15, Volume: 179, Issue:6 Topics: Animals; Dog Diseases; Dogs; Female; Pemphigoid, Bullous; Prednisolone; Skin Diseases, Vesiculobullo	1981
Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients. The British journal of dermatology, 1995, Volume: 133, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Combined Modality Therapy; Drug Administra	1995
Bullous pemphigoid in an infant. The Australasian journal of dermatology, 1995, Volume: 36, Issue:2 Topics: Autoantibodies; Fluorescent Antibody Technique; Humans; Infant; Male; Pemphigoid, Bullous; Prednisol	1995
[Pemphigoid in children]. Annales de dermatologie et de venereologie, 1994, Volume: 121, Issue:9 Topics: Facial Dermatoses; Fluorescent Antibody Technique; Humans; Infant; Male; Pemphigoid, Bullous; Predni	1994
Bullous pemphigoid in a 4-month-old boy. The British journal of dermatology, 1994, Volume: 131, Issue:3 Topics: Humans; Immunoglobulin G; Infant; Male; Pemphigoid, Bullous; Prednisolone	1994
Dyshidrosiform pemphigoid induced by nickel in the diet. Contact dermatitis, 1993, Volume: 29, Issue:3 Topics: Adult; Female; Food Hypersensitivity; Foot Dermatoses; Hand Dermatoses; Humans; Nickel; Pemphigoid,	1993
Bullous pemphigoid in infancy--a case report including new immunoblotting observations. Clinical and experimental dermatology, 1993, Volume: 18, Issue:5 Topics: Humans; Immunoblotting; Immunoglobulin G; Infant; Male; Pemphigoid, Bullous; Prednisolone; Skin	1993
Pemphigoid gestationis occurring in a patient with HELLP syndrome. The Australasian journal of dermatology, 1996, Volume: 37, Issue:2 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Cesarean Section; Female; Fluorescent Antibod	1996
Bullous pemphigoid--a report of 86 cases from Taiwan. Clinical and experimental dermatology, 1996, Volume: 21, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Case-Control Studies; Child; D	1996
Bullous pemphigoid in an HB virus carrier: interaction between corticosteroids and HB virus. The Journal of dermatology, 1997, Volume: 24, Issue:3 Topics: Carrier State; Female; Hepatitis B; Humans; Liver Failure; Middle Aged; Pemphigoid, Bullous; Prednis	1997
Bullous pemphigoid in an infant: a case report and literature review. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1997, Volume: 80, Issue:4 Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Infant; Pemphigoid, Bullous; Pred	1997
Kaposi's sarcoma associated with immunosuppression for bullous pemphigoid. The British journal of dermatology, 1997, Volume: 137, Issue:1 Topics: Aged; Aged, 80 and over; Azathioprine; Humans; Immunosuppressive Agents; Leg; Male; Pemphigoid, Bull	1997
Combination chemotherapy in a patient with severe multiple systemic autoimmune disease. Clinical and laboratory haematology, 1998, Volume: 20, Issue:5 Topics: Anemia, Hemolytic, Autoimmune; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressiv	1998
Penicillamine in the etiology of bullous pemphigoid. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:12 Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans;	1998
Bullous pemphigoid showing unusual ocular changes. The British journal of dermatology, 1998, Volume: 139, Issue:4 Topics: Aged; Animals; Anti-Inflammatory Agents; Betamethasone; Corneal Opacity; Diagnosis, Differential; Fe	1998
Benign symmetric lipomatosis in a Chinese man with bullous pemphigoid. International journal of dermatology, 1999, Volume: 38, Issue:2 Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; China; Humans; Lipomatosis, Multiple Symmetric	1999
Corticosteroid-induced pancreatitis in patients with autoimmune bullous disease: case report and prospective study. Dermatology (Basel, Switzerland), 1999, Volume: 198, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amylases; Analysis of Variance; Female; Hum	1999
[Recurrent bleeding tendency due to factor VIII inhibitor during therapy for bullous pemphigoid]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:10 Topics: Aged; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Factor VIII; Female; He	1999
Pemphigoid nodularis with IgA autoantibodies against the intracellular domain of desmoglein 1. The British journal of dermatology, 2000, Volume: 142, Issue:1 Topics: Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Cytoskeletal Proteins; Desmoglein 1; Desmoglei	2000
Dermatitis herpetiformis evolving into bullous pemphigoid: a probable example of 'epitope spreading'. Clinical and experimental dermatology, 2000, Volume: 25, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Dermatitis He	2000
Bullous pemphigoid and neurofibromatosis-a chance association requiring special vigilance. Clinical and experimental dermatology, 2000, Volume: 25, Issue:8 Topics: Anti-Inflammatory Agents; Female; Humans; Middle Aged; Neurofibromatosis 1; Pemphigoid, Bullous; Pre	2000
[Bullous scabies and scabies-triggered bullous pemphigoid]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:1 Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Ant	2001
[Recurrence of bullous pemphigoid after surgery: report of a case]. Masui. The Japanese journal of anesthesiology, 2001, Volume: 50, Issue:4 Topics: Adult; Female; Humans; Hysterectomy; Pemphigoid, Bullous; Postoperative Period; Prednisolone; Recurr	2001
Development of a bullous pemphigoid after split-skin grafting. British journal of plastic surgery, 2001, Volume: 54, Issue:5 Topics: Aged; Anti-Inflammatory Agents; Female; Fluorescent Antibody Technique, Direct; Humans; Pemphigoid,	2001
Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use. Singapore medical journal, 2001, Volume: 42, Issue:10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Female; Humans; Immunosuppressive Agen	2001
A case of localized pemphigoid with loss of toenails. Dermatology (Basel, Switzerland), 2002, Volume: 204, Issue:2 Topics: Aged; Female; Humans; Nail Diseases; Pemphigoid, Bullous; Prednisolone; Toes	2002
Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Archives of dermatology, 2002, Volume: 138, Issue:7 Topics: Aged; Aged, 80 and over; Cause of Death; Cohort Studies; Female; Follow-Up Studies; Glucocorticoids;	2002
Decompensation in proteinase-inhibitor system and application of proteinase inhibitors in pemphigus and pemphigoid. Journal of dermatological science, 1992, Volume: 4, Issue:2 Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Pemphigoid, Bullous; Pemphigus; Prednisolone; Serine	1992
Lack of predictive factors for the clinical course of bullous pemphigoid. Journal of the American Academy of Dermatology, 1992, Volume: 26, Issue:4 Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Dapsone; Drug Therapy, Combination; Fema	1992
Bullous diseases in Malaysia: epidemiology and natural history. International journal of dermatology, 1992, Volume: 31, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; China; Dermatitis Herpetiformis; Ethnicity; Femal	1992
Steroid-resistant bullous pemphigoid treated with cyclosporin A. Clinical and experimental dermatology, 1991, Volume: 16, Issue:1 Topics: Aged; Cyclosporins; Drug Resistance; Female; Humans; Osteoporosis; Pemphigoid, Bullous; Prednisolone	1991
Clinical and laboratory evaluation of hemocarboadsorption in autoimmune bullous dermatoses. The International journal of artificial organs, 1990, Volume: 13, Issue:3 Topics: Adsorption; Adult; Aged; Animals; Autoantibodies; Autoimmune Diseases; Carbon; Female; Gossypol; Hem	1990
The use of chlorambucil in the treatment of bullous pemphigoid. Journal of the American Academy of Dermatology, 1990, Volume: 22, Issue:5 Pt 1 Topics: Age Factors; Aged; Aged, 80 and over; Chlorambucil; Drug Administration Schedule; Drug Therapy, Comb	1990
Vesicular pemphigoid--ultrastructural and immunoelectron microscopic study. Dermatologica, 1989, Volume: 178, Issue:4 Topics: Aged; Basement Membrane; Complement C3; Dapsone; Drug Therapy, Combination; Female; Humans; Immunogl	1989
Acute pancreatitis: a fatal complication of treatment of bullous pemphigoid with systemic corticosteroids. Dermatologica, 1989, Volume: 179, Issue:2 Topics: Acute Disease; Aged; Depressive Disorder; Hemorrhage; Humans; Male; Pancreatitis; Pemphigoid, Bullou	1989
[Bullous pemphigoid associated with IgA nephropathy: a case report]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:7 Topics: Aged; Glomerulonephritis, IGA; Humans; Male; Nephrotic Syndrome; Pemphigoid, Bullous; Prednisolone;	1989
Adjuvant therapy of bullous pemphigoid with dapsone. Clinical and experimental dermatology, 1989, Volume: 14, Issue:2 Topics: Adult; Aged; Azathioprine; Dapsone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pe	1989
Haemorrhagic pompholyx is a sign of bullous pemphigoid and an indication for low-dose prednisolone therapy. Clinical and experimental dermatology, 1986, Volume: 11, Issue:4 Topics: Aged; Eczema, Dyshidrotic; Female; Hemorrhage; Humans; Male; Pemphigoid, Bullous; Prednisolone; Skin	1986
[Treatment of bullous pemphigoid by plasma exchange and prednisolone]. Presse medicale (Paris, France : 1983), 1985, May-18, Volume: 14, Issue:20 Topics: Aged; Autoantibodies; Basement Membrane; Female; Humans; Male; Pemphigoid, Bullous; Plasma Exchange;	1985
[Immediate treatment of bullous pemphigus with a corticosteroid-cyclophosphamide combination]. Annales de dermatologie et de venereologie, 1986, Volume: 113, Issue:12 Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Cyclophosphamide; Dexamethasone; Drug Therapy, Com	1986

prednisolone and Pemphigoid, Bullous